Updates on the Management of Patients With Lymphomas During the COVID-19 Pandemic

Download All
Learn how multidisciplinary experts overcome clinical challenges to optimal care of patients with lymphomas during the COVID-19 pandemic with this expert commentary, slideset, and frequently asked questions adapted from healthcare professionals’ questions posed during a live webinar.
Lydia Scarfò, MD

ClinicalThought

Early prospective data show a low rate of seroconversion in patients with CLL who received COVID-19 mRNA vaccines. How can we improve vaccine protection against COVID-19 in this vulnerable patient population?

Lydia Scarfò, MD Released: August 27, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue